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ABSTRACT 
 
           CHB is a common disease especially among elderly people. 
Objectives: The aim of the study is to know the clinical 
manifestations of CHB and to assess the different modes of cardiac 
pacing and their short-term outcome. 
Methods: Descriptive analytical cross-sectional study that was 
performed in SHC, 70 patients who presented with CHB and 
underwent cardiac pacing were studied.  
         Data analyzed and tabulated including personal data, 
presenting symptoms and signs, investigations, modes of cardiac 
pacing and their outcome. 
Results: Male to female ratio 1.3 : 1. 
          The main presenting symptoms were S.O.B 52.3% syncope  
45.7% and dizziness 40%. 
         The main signs were bradycardia 88.4%, systolic 
hypertension 45.7% and signs of congestive heart failure 25.7%. 
ECG is the diagnostic investigation.  
Different modes of cardiac pacing were implanted including VDD 
54.3%, VVI  25.7% and DDD 12.9%. 
         Short-term outcome of cardiac pacing is good, 91.4% of the 
patients improved. 
Conclusion: CHB is a common disease in the elderly people and 
cardiac pacing is a life saving procedure.  
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  ﻣﻠﺨــﺺ اﻷﻃـﺮوﺣـﺔ
  
  :هﺪف اﻟﺪراﺳﺔ
دراﺳﺔ اﻷﻋﺮاض واﻟﻌﻼﻣﺎت اﻟﻨﺎﺗﺠﺔ ﻣﻦ ﻣﺮض إﺣﺼﺎر اﻟﻘﻠﺐ اﻟﻜﺎﻣﻞ واﻟﺘﻌﺮف 
  .ﻋﻠﻰ اﻷﻧﻮاع اﻟﻤﺨﺘﻠﻔﺔ ﻣﻦ أﺟﻬﺰة ﺗﻨﻈﻴﻢ ﺿﺮﺑﺎت اﻟﻘﻠﺐ اﻟﻤﺴﺘﺨﺪﻣﺔ وﻧﺘﺎﺋﺠﻬﺎ
  
  :اﻟﻄﺮﻳﻘﺔ
وﻗﺪ  ﻣﺮﻳﺾ ﻳﻌﺎﻧﻮن ﻣﻦ إﺣﺼﺎر اﻟﻘﻠﺐ 07هﺬﻩ دراﺳﺔ وﺻﻔﻴﺔ ﺗﺤﻠﻴﻠﻴﺔ أﺟﺮﻳﺖ ﻋﻠﻰ 
  .أﺟﺮﻳﺖ ﻟﻬﻢ ﻋﻤﻠﻴﺔ زراﻋﺔ ﺟﻬﺎز ﺗﻨﻈﻴﻢ ﺿﺮﺑﺎت اﻟﻘﻠﺐ ﺑﻤﺮآﺰ اﻟﺴﻮدان ﻟﻠﻘﻠﺐ
ﺗﻢ ﺟﻤﻊ اﻟﻤﻌﻠﻮﻣﺎت ﺑﺎﺳﺘﺨﺪام اﺳﺘﺒﻴﺎن ﻋﻦ اﻟﻤﺮض واﻋﺮاﺿﻪ وﻋﻼﻣﺎﺗﻪ ، وﺳﺎﺋﻞ 
ﺗﺸﺨﻴﺼﻪ ، اﻷﻧﻮاع اﻟﻤﺨﺘﻠﻔﺔ ﻣﻦ أﺟﻬﺰة ﺗﻨﻈﻴﻢ ﺿﺮﺑﺎت اﻟﻘﻠﺐ اﻟﺘﻲ ﺗﻢ اﺳﺘﺨﺪاﻣﻬﺎ واﻟﻨﺘﺎﺋﺞ 
  .اﻟﻤﺘﺮﺗﺒﺔ ﻋﻠﻰ ذﻟﻚ
  
  :اﻟﻨﺘﺎﺋﺞ
 .1 : 3.1ر ﻟﻺﻧﺎث ﻧﺴﺒﺔ اﻟﺬآﻮ -
 %.04، دوﺧﺎن % 7.54، إﻏﻤﺎء % 3.25أهﻢ اﻷﻋﺮاض ﺿﻴﻖ ﻓﻲ اﻟﺘﻨﻔﺲ  -
، ارﺗﻔﺎع  ﺿﻐﻂ اﻟﺪم % 4.88أهﻢ اﻟﻌﻼﻣﺎت ﺑﻄﺊ ﺷﺪﻳﺪ ﻓﻲ ﻣﻌﺪل ﺿﺮﺑﺎت اﻟﻘﻠﺐ  -
 %.7.52، هﺒﻮط ﻓﻲ اﻟﻘﻠﺐ % 7.54
ﻣﻦ اﻟﻤﺮﺿﻰ ﺗﺤﺴﻨﺖ ﺣﺎﻟﺘﻬﻢ ﺑﻌﺪ ﻋﻤﻠﻴﺔ زراﻋﺔ ﺟﻬﺎز ﺗﻨﻈﻴﻢ ﺿﺮﺑﺎت % 4.19 -
 .اﻟﻘﻠﺐ
  
  :اﻟﺨﻼﺻﺔ
ر اﻟﻘﻠﺐ اﻟﻜﺎﻣﻞ ﻣﺮض ﻣﻨﺘﺸﺮ ﻋﻨﺪ اﻟﻤﺴﻨﻴﻦ وﻋﻤﻠﻴﺔ زراﻋﺔ ﺟﻬﺎز ﺗﻨﻈﻴﻢ إﺣﺼﺎ
 .ﺿﺮﺑﺎت اﻟﻘﻠﺐ ﺗﻨﻘﺬ ﺣﻴﺎﺗﻬﻢ
 iv
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INTRODUCTION & LITERATURE 
REVIEW 
COMPLETE HEART BLOCK 
The Conduction System Of The Heart 
Each natural heart beat begins in the hearts pacemaker-the 
sinoatrial (SA) node. This is a crescent-shaped structure that is located 
around the medial and anterior aspect of the junction between the 
superior vena cava and the right atrium. Progressive loss of the diastolic 
resting membrane potential is followed, when the threshold potential has 
been reached, by a more rapid depolarization of the sinus node tissue, 
and this triggers depolarization of the atrial myocardium .The atrial 
tissue is activated like a forest fire ,but activation goes out when the 
insulting layer between the atrium and ventricle-the annulus fibrosus- is 
reached .                                                                                             
The conductive system of the heart is organized so that the 
cardiac impulse will travel from the atria to the ventricles slowly. This 
delay allows time for the atria to empty their contents into the ventricles 
before ventricular contraction begins. It is primarily the atrioventricular 
(AV) node and its adjacent conductive fibres that delay the transmission 
of the cardiac impulse partly because of their considerably smaller size 
than that of the normal atrial muscle fibres. However, most of the slow 
coduction is probably caused by two other different  factors. First, all 
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these fibres have resting membrane potentials that are much less 
negative than the normal resting potential of other cardiac muscle. 
Second, few gap junctions connect the successive muscle cells in the 
pathway, so there is great resistance to the conduction of excitatory ions 
from one cell to the next. 
The atrioventricular (AV) node is a small bean-shaped structure 
that lies beneath the right atrial endocardium within the lower interatrial 
septum. It continues as the His bundle, which penetrates the annulus 
fibrosus and conducts the cardiac impulse rapidly towards the ventricles. 
The His bundle divides into the right and main left bundle branches The 
right bundle branch continues down the right side of the interventricular 
septum to the apex, from where it radiates to form the Purkinje network, 
which spreads throughout the subendocardial surface of the right 
ventricle. The main left bundle branch is a short structure, which fans 
out into many strands on the left side of the interventricular septum, and 
these strands can be grouped into the anterior hemibundle which 
supplies the subendocardial Purkinje network of the anterior and 
superior surfaces of the left ventricle, and the posterior hemibundle that 
supplies the inferior and posterior surfaces. The impulse conduction 
through the AV node depends on the action potentials largely produced 
by slow transmembrane calcium influx, while that in the atria, ventricles 
and His-Purkinje system is due to action potentials generated by rapid 
transmembrane sodium diffusions .(1,2)  
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Definition of Atrioventricular Block: 
A trioventricular (AV) block can be defined as a delay or 
interruption in the transmission of a cardiac impulse from the atria to the 
ventricles due to an anatomical or functional impairment in the 
conduction system. This can be transient or permanent. The conduction 
can be delayed, intermittent, or absent  resulting in first degree(slowed 
conduction), second degree(missed beats, often in a regular pattern), and 
third degree or complete AV block respectively.(show ECG). 
First Degree AV Block: 
During first degree AV block, every atrial impulse conducts to the 
ventricles, producing a regular ventricular rate, but the P-R interval 
exceeds 0-2 seconds in the adult. Sometimes the P-R interval is very 
prolonged exceeding the P-P interval, a phenomenon known as 
“Skipped” P waves. Clinically important P-R interval prolongation can 
result from conduction delay in the AV node (A-H interval), in the His-
Purkinje system (H-V interval), or at both sites.  
Acceleration of the atrial rate or enhancement of vagal tone by 
carotid massage can cause first degree AV nodal block to progress to 
type I second degree AV block. Conversely, type I second degree AV 
nodal block can revert to first degree block with deceleration of the 
sinus rate. 
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Second Degree AV Block: 
The block of some atrial impulses conducted to the ventricle at a 
time when physiological interference is not involved constitutes second 
degree AV block. 
Wenckebach and Hay, by analyzing the a-c and V waves in the 
JVP, described two types of second degree AV block. After the 
introduction of the electrocardiograph, Mobitz classified them as type I 
and type II. Electrocardiographically, typical type I second degree AV 
block (Wenckeback or Mobitz type I) is characterized by progressive P-
R prolongation culminating in a nonconducted  P wave, while in type II 
second degree AV block (Mobitz type II), the P-R interval remains 
constant prior to the blocked P wave. In most instances, the 
differentiation between type I  and type II second degree AV blocks can 
be made easily and reliably from the surface ECG. Often type II AV 
block can progress to complete AV block with development of Stokes-
Adams syncope, while type I AV block is generally more benign and 
does not progress to more advanced forms of AV conduction 
disturbances. 
In a patient with an acute myocardial infarction (MI), type I AV 
block usually accompanies inferior MI, is transient, and does not require 
temporary pacing, whereas type II AV block occur in the setting of 
anterior MI, can require temporary or permanent pacing, and is 
associated with high rate of mortality, generally due to pump failure(3).     
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Third Degree (Complete) AV Block: 
Third degree is a disorder of the cardiac conduction system with 
complete absence of AV conduction. No P waves conduct to the 
ventricles, and AV dissociation is complete. 
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Pathophysiology of Complete AV block: 
In complete (AV) block no atrial  impulses reach the ventricles. 
The block can exist in the AV node or in the infranodal specialized 
conduction system (4-6). A His-bundle electrocardiographic study can 
determine the site of the block quite accurately, but the  escape rhythm 
can provide important clues. 
The escape rhythms occur when a pacemaker other than the SA 
node has sufficient time to depolarize, attain threshold, and produce a 
depolarization. In CHB, the escape rhythm that controls the ventricles 
can occur at any level below that of the conduction block and the 
morphology of the QRS complexes can help to determine the location at 
which the escape rhythm pacemaker is occurring: 
• If the block occurs at the AV node, about two-thirds of the escape 
rhythms have a narrow QRS complexes, i.e., a junctional or AV 
nodal rhythm.(7-9) 
• Block at the level of the bundle of His is also typically with a narrow 
QRS complex. 
• Patients with trifascicular block have a subjunctional escape rhythm 
with a wide QRS complex. 
• If the escape rhythm has a normal QRS complex, the block occurs 
with almost equal frequency in the AV node and the bundle of His.(6) 
As a general rule, the more distal the block, the slower will be the 
escape pacemakers, and those patients are haemodynamically unstable. 
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The effects of autonomic tone, exercise, and atropine may all be 
helpful in determining the site of the block.(8,10-15)High junctional  
pacemakers may respond with an increase in the heart rate to 
catecholamines, exercise, or atropine, and a decrease in heart rate after 
vagal maneuvers. In comparison, lower pacemakers are less responsive 
to autonomic manipulations. 
Eatiology of CHB: 
Many processes can affect the atrioventricular (AV) conduction 
system. However, the most common are fibrosis and sclerosis 
(sclerodegenerative changes) of the conduction system and ischemic 
heart disease. 
Fibrosis and sclerosis – Fibrosis and sclerosis of the conduction 
system accounts for about one-half of cases of AV block and may be 
induced by several different conditions which often cannot be 
distinguished clinically(16).  
Lenègre's disease, for example, is a sclerodegenerative affliction of 
the conduction system with some predilection for the right bundle 
branch and the left anterior fascicle in individuals over 50 years of 
age(17). It is frequently associated with slow progression to complete 
heart block. 
Lev's disease (18,19) is caused by fibrosis or calcification extending 
from any of the fibrous structures adjacent to the conduction system 
into the conduction system. Fibrosis of the top of the muscular septum 
is a common cause of right bundle branch block with left anterior 
fascicular block in the elderly patient. Calcification or fibrosis can 
also extend from the mitral or aortic valve rings into the conduction 
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system. Involvement of the mitral ring or the central fibrous body, for 
example, may be the most common cause of complete heart block 
with a narrow QRS complex in the elderly. Aortic valve calcification, 
on the other hand, can invade the bundle of His, the right and/or left 
bundle branch as well as the left anterior fascicle. Thus, the QRS 
complex may be prolonged. 
Ischemic heart disease – Ischemic disease accounts for about 40 
percent of cases of AV block (16). Conduction can be disturbed with 
either chronic ischemic disease or during an acute myocardial 
infarction (20-24). It is estimated that approximately 20 percent of 
patients with an acute myocardial infarction develop AV block: 8 
percent with first degree; 5 percent with second degree; and 6 percent 
with third degree (22-24). 
Intraventricular conduction disturbances (IVCDs), including bundle 
and fascicular blocks, also occur in 10 to 20 percent of cases of acute 
myocardial infarction (25-31). Left bundle branch block and right bundle 
branch block with left anterior fascicle block are most common, each 
occurring in about one-third of patients with an IVCD (29). RBBB with 
or without left posterior fascicular block and alternating bundle 
branch block are less frequently seen while isolated left anterior or 
posterior fascicle block is distinctly unusual 
Drugs – A variety of drugs can impair conduction and cause AV 
block. Examples include digitalis, calcium channel blockers 
(especially verapamil and to a lesser extent diltiazem), amiodarone 
and ß-blockers (32,33). In comparison, antiarrhythmic drugs that 
modulate the sodium channel, such as quinidine, procainamide, and 
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disopyramide, can produce block in the more distal His-Purkinje 
system. 
Increased vagal tone – Enhanced vagal tone due to pain, carotid sinus 
massage, or hypersensitive carotid sinus syndrome can result in 
slowing of the sinus rate and/or the development of AV block. 
Valvular disease – As noted above, calcification and fibrosis of the 
aortic or mitral valve rings can extend into the conducting system. In 
addition, AV block is not uncommonly associated with replacement of 
a calcified aortic or mitral valve (34), closure of a ventricular septal 
defect, or other surgical procedures (19,35-37). 
Congenital heart disease – Congenital complete heart block may be 
an isolated lesion or may be associated with other types of congenital 
heart disease. 
Others – AV block can also occur in a variety of other disorders: 
  • Cardiomyopathies, including hypertrophic obstructive 
cardiomyopathy and infiltrative processes such as amyloidosis and 
sarcoidosis (18,19,38). 
  • Myocarditis due to rheumatic fever, diphtheria, viruses, systemic 
lupus erythematosus, toxoplasmosis, bacterial endocarditis, syphilis, 
and other causes (39-49). The development of AV block in this setting is 
often a poor prognostic sign. 
  • Hyperkalemia, usually when the plasma potassium concentration is 
above 6.3 meq/L (50-52). 
  • Infiltrative malignancies, such as Hodgkin's disease and other 
lymphomas, and multiple myeloma (18,19). 
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  • Neuromuscular heredodegenerative disease(17-19,53-55), 
dermatomyositis, rheumatoid disease, Paget's disease, 
hyperthyroidism, and myxedema (18,19). 
  • Cardiac tumors, cysts (17-19,56), myocardial bridging (57), and 
trauma(18,19,58). 
Clinical Manifestations: 
History: 
Patients may be asymptomatic, or may have minimal symptoms, 
usually those with narrow complex escape rhythm, related to 
hypoperfusion including fatigue, dizziness, and impaired exercise 
tolerance(59). 
More commonly, patients are profoundly symptomatic mostly due 
to bradycardia. They present frequently with dizziness or syncope. 
These are disturbances of consciousness due to an associated profound 
fall in blood pressure, which can also be the result of tachycardia. 
Cardiac syncope occurs typically without warning and often with 
resultant self-injury. These attacks, known as Stokes-Adams syncope, 
are usually of short duration and self-limiting but they have mortal 
potential. During the attack the unconscious patient is pale but if the 
episode is prolonged cyanosis ensues with epileptiform seizures. On 
recovery the patient flushes and full consciousness is restored rapidly, 
usually without amnesia or neurological sequelae, but on occasion 
neurological damage may result from systemic embolism, particularly in 
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SA node disease, or may be the consequence of co-existing local 
cerebral arterial disease.   
Another presentation is with congestive cardiac failure. In this 
context presentation is more often of a bradycardia than sustained 
tachycardia. Severe bradycardia, particularly in the elderly may result in 
mental confusion, dementia or renal dysfunction due to low cardiac out 
put. 
It is important to recognize that recurrent falls may be due to 
transient disturbances of consciousness when cases may be referred to 
orthopaedic, geriatric or neurological departments.  
There is no difference in incidence of bradycardia due to SA node 
disease or AV block between the sexes and the average age of 
presentation is 70 years(60).   
Patients also may have associated symptoms of acute (MI)(59).   
Physical Examination: 
Physical examination will be notable for bradycardia which may 
be profound. 
The physical findings include a variable intensity of the first heart 
sound as the P-R interval changes, atrial sounds, and a waves in the JVP 
lacking a consistent relationship to ventricular contraction. Intermittent 
large (Cannon) a waves may be seen in the JVP when atrial and 
ventricular contraction occur simultaneously. The second heart sound 
can split normally or paradoxically, depending on the manner of 
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ventricular activation. A premature beat representing a ventricular 
capture can interrupt a regular heart rhythm. 
When the ventricular rate exceeds the atrial rate, a cardiac 
increase in intensity of the first heart sound is produced as the P-R 
internal shortens followed by a very loud sound (bruit de cannon). This 
is followed by a sudden reduction in intensity of the first heart sound 
and the appearance of giant a waves(3). 
Symptomatic patients may have signs of hypoperfusion, including : 
• Hypotention. 
• Altered mental status. 
• Lethargy. 
Signs of congestive heart failure may be present. 
In patients with concomitant MI, signs of acute MI may be evident. 
Regularized atrial fibrillation is the classic sign of CHB due to digitalis 
toxicity(59). 
Treatment : 
Therapy begins by looking for and correcting reversible causes 
of slowed conduction such a myocardial ischemia, increased vagal 
tone, and drugs that depress conduction.  
The recommendations contained in the Report of the American 
College of Cardiology/American Heart Association Task Force on 
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Practice Guidelines (Committee on Pacemaker Implantation) for 
insertion of a pacemaker for third degree AV block are as follows(61). 
GROUP 1: DEFINITE INDICATIONS FOR PACING – Group 1 
includes conditions in which implantation of a cardiac pacemaker is 
considered acceptable and necessary, provided that the condition is 
chronic or recurrent and is not due to a transient cause, such as acute 
myocardial infarction, drug interaction, and electrolyte imbalance. If 
the rhythm disturbance is chronic or recurrent, a single episode of a 
symptom such as syncope, presyncope, or seizure is sufficient to 
establish medical necessity. 
Group 1 indications include: 
  • Acquired complete atrioventricular (AV) block. Some controversy 
exists concerning pacing in asymptomatic patients. The current 
ACC/AHA Guidelines continue to classify asymptomatic third degree 
AV block, at any anatomic site, with average awake ventricular rates 
of 40 bpm or faster as a Class IIA indication (61). Nevertheless, others 
consider this condition a group 1 indication (62). There are many 
disorders that may be responsible for acquired AV block. 
  • Following an acute myocardial infarction when there is persistent 
second degree AV block in the His-Purkinje system with bilateral 
bundle branch block or third degree AV block within or below the 
His-Purkinje system, transient advanced infranodal AV block and 
associated bundle branch block, and persistent and symptomatic 
second or third degree AV block  
  • Congenital complete heart block with severe bradycardia, 
significant symptoms, wide QRS escape rhythm, ventricular 
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dysfunction, or, if asymptomatic, ventricular rates <50 to 55 bpm in 
an infant and <70 bpm when associated with congenital heart disease  
  • Symptomatic Mobitz II AV block.  
Asymptomatic Mobitz II second degree AV block is considered a 
class IIA indication for pacing in the most recent ACC/AHA 
guidelines under the category of "acquired AV block", but it is a class 
I indication under the category of "chronic bifascicular and 
trifascicular block". Many would agree that this should routinely be 
considered a class I indication for pacing (63). 
  •  Symptomatic Mobitz I AV block (64). 
  •  Symptomatic sinus bradycardia in which the symptoms are clearly 
related to the bradycardia The most significant symptoms include 
syncope, seizures, congestive heart failure, dizziness, or confusion in 
patients with a heart rate below 40 beats/min. Symptomatic 
chronotropic incompetence is also a Class I indication for pacing. 
  • Neurocardiogenic syndromes with significant symptoms including 
but not limited to syncope and near-syncope. 
Other indications for pacing – Other indications for pacing include: 
  • A less distinct group of patients with sinus bradycardia of lesser 
severity (heart rate >40 beats/min) who complain of dizziness or 
confusion that correlates with the slower rates 
  • Bradycardia that is the consequence of long-term drug therapy for 
which there is no acceptable alternative 
  • Bradycardia-induced ventricular arrhythmia or tachycardia which is 
potentially life-threatening. 
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  •  Exercise-induced AV block, even if asymptomatic, that is not 
demonstrated to be secondary to myocardial ischemia. In the absence 
of ischemia, almost all cases of exercise-induced AV block are due to 
disease of the His-Purkinje system (63) 
GROUP 2: POSSIBLE INDICATIONS FOR PACING – Group 2 
includes conditions in which use of a cardiac pacemaker may be 
acceptable or necessary, provided that the medical history and 
prognosis of the patient can be documented and that there is evidence 
that pacemaker implantation will assist in overall management. 
  •Asymptomatic type 1 second degree AV block at intra- or infra-His 
levels when found incidentally at the time of electrophysiologic study 
performed for other reasons. 
  •First degree AV block when there is hemodynamic compromise 
because of effective AV dissociation secondary to a very long PR 
interval. 
  •Congenital complete heart block, beyond the first year of life, with 
an average heart rate <50 bpm , or with abrupt pauses in the 
ventricular rate which are double or triple the basic cycle length. 
  •Bifascicular or trifascicular block accompanied by syncope that is 
attributed to transient complete heart block after other plausible 
causes of syncope have been reasonably excluded . 
  •Markedly prolonged HV interval (>100 ms) in an asymptomatic 
patient or pacing-induced infra-His block that is not physiologic and 
which is found incidentally at the time of electrophysiologic study 
performed for other reasons. 
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  •Persistent second or third degree AV block at the AV node level 
following an acute myocardial infarction . 
  • Asymptomatic Mobitz II second-degree AV block. 
  •Symptomatic sinus bradycardia (heart rate <40 beats/min) in which 
there is not a clear association between the bradycardia and significant 
symptoms. Chronic heart rates of <30 bpm in the awake and 
minimally symptomatic patient is considered a class IIB indication. 
  •In the patient with neurocardiogenic syncope, recurrent syncope 
without clear provocative events and with an abnormal response to 
carotid sinus massage is considered a class IIA indication. Neurally 
mediated syncope with significant bradycardia that can be reproduced 
by a tilt study or other provocative maneuvers is considered a Class 
IIB indication.  
  • Pacing in the patient with hypertrophic cardiomyopathy when there 
is medically refractory, symptomatic patients with significant resting 
or provoked LV outflow obstruction is now considered a Class IIB 
indication (61). 
  • Symptomatic, drug refractory dilated cardiomyopathy with first 
degree AV block when acute hemodynamic studies have 
demonstrated hemodynamic benefit from pacing is considered a class 
IIB indication. 
  • Overdrive pacing in patients with recurrent and refractory 
ventricular tachycardia to prevent ventricular tachycardia. 
GROUP 3: PACING NOT INDICATED – The following conditions 
are considered to lack adequate evidence of benefit from permanent 
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pacing; as a result, they should not be considered appropriate 
indications for permanent pacing. 
  • Syncope of undetermined etiology. This may require extensive 
investigation, including ambulatory monitoring, neurological 
evaluation, and electrophysiologic testing (including tilt-table testing). 
Cardiac pacing may be considered if the history strongly suggests that 
the syncope is of cardiogenic origin. In such cases, the patient must 
understand that permanent pacing may not alleviate the symptoms, 
since no correlation between symptoms and rhythm has been 
documented.  
  • Sinus bradycardia without significant symptoms. 
  •  Sinoatrial block or sinus arrest without significant symptoms. 
  •  Asymptomatic prolonged RR intervals with atrial fibrillation or 
other causes of transient ventricular pause. 
  •  Asymptomatic bradycardia during sleep. 
  •  Asymptomatic second-degree Mobitz I (Wenckebach) AV block. 
  •  Right bundle branch block with left axis deviation without syncope 
or other symptoms of intermittent AV block. 
  •  Reversible AV block, such as those associated with electrolyte 
abnormalities, Lyme disease, sleep apnea, enhanced vagal tone, and 
some cases that occur postoperatively (63). 
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NOMENCLATURE - A three-letter code describing the basic 
function of the various pacing systems was first proposed in 1974 by a 
combined task force from the American Heart Association and the 
American College of Cardiology. Since that time, responsibility for 
periodically updating the code has been assumed by a committee 
consisting of members of the North American Society of Pacing and 
Electrophysiology (NASPE) and the British Pacing and 
Electrophysiology Group (BPEG). The code is designated the NBG 
code for pacing nomenclature; it has five positions, with the fifth 
position being rarely used (show table)(65). 
The code is generic and does not describe specific or unique 
functional characteristics for each device. The first three positions are 
restricted to bradycardia support pacing.  
Position I – The first position reflects the chamber or chambers in 
which stimulation and pacing occur. A refers to the atrium; V 
indicates the ventricle; and D means dual chamber, i.e., both atrium 
and ventricle. 
Position II – The second position refers to the chamber or chambers 
in which sensing occurs. The letters are the same as those for the first 
position (i.e., A refers to atrium, V for ventricle, D means dual 
chamber (atrium and ventricle), and O for absence of sensing). 
Manufacturers also use S in both the first and second positions to 
indicate that the device is capable of pacing only a single cardiac 
chamber. Once the device is implanted and connected to a lead in 
either the atrium or the ventricle, S should be changed to either A or V 
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in the clinical record to reflect the chamber in which pacing and 
sensing are occurring. 
Position III – The third position refers to the mode of sensing, or how 
the pacemaker responds to a sensed event. 
  •I indicates that a sensed event inhibits the output pulse and causes 
the pacemaker to recycle for one or more timing cycles. 
  •T means that an output pulse is triggered in response to a sensed 
event. 
  •D means that there are dual modes of response. This designation is 
restricted to dual chamber systems. An event sensed in the atrium 
inhibits the atrial output but triggers a ventricular output. Unlike the 
single chamber triggered mode, in which an output pulse is triggered 
immediately on sensing, there is a delay in the dual chamber mode 
between the sensed atrial event and the triggered ventricular output to 
mimic the normal PR interval. If a native ventricular signal or R wave 
is sensed, it will inhibit the ventricular output and possibly even the 
atrial output, depending upon where sensing occurs. 
Position IV – The fourth position of the code reflects both 
programmability and rate modulation. 
  •R in the fourth position indicates that the pacemaker incorporates a 
sensor to control the rate independently of intrinsic electrical activity 
of the heart (i.e., rate responsive or rate adaptive pacing). Such 
pacemakers have the capability of increasing their pacing rate during 
exercise in response to vibration, minute ventilation, temperature, 
oxygen saturation, or other stimuli. Virtually all pacemakers with               
a sensor also have extensive telemetric and programmable 
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capabilities. There is insufficient space within the code to indicate 
which sensor is being used. From a practical standpoint, R is the only 
indicator commonly used in the fourth position. 
  •O indicates that none of the settings of the pacing system can be 
noninvasively altered. 
  •P is simple programmability; one or two variables can be changed, 
but this code does not specify which ones. 
  •M is multiparameter programmability, which means that three or 
more parameters can be changed. 
  •C reflects the ability of the pacemaker to communicate with the 
programmer; namely, it has telemetry. By convention, it also means 
that the pacemaker has multiparameter programmability. 
Position V – The fifth position is restricted to antitachycardia 
functions and is rarely used 
TECHNOLOGY OF   PACEMAKERS: 
        Pacemakers are manufactured under rigorous conditions of 
cleanliness and quality assurance. The unit, weighing 25 to 40 g, 
contains a battery, which is commonly lithium-iodine cell developed 
especially for pacemakers. This cell has the advantage of high power to 
weight and size ratios, predictable discharge behaviour, and long life up 
to 10 years with low current drain from circuit and electrode. The other 
major component is the pulse forming circuitry, which of hybrid type 
using a silicone chip with the addition of a few discrete components. All 
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pacemakers have a, sensing, capability where an amplifier picks up 
spontaneous cardiac activity and uses this to recycle the pacemaker’s 
out put. Thus, if the patient returns to normal sinus rhythm, the 
pacemaker output is inhibited; as soon as the rate of the spontaneous 
rhythm falls below the set rate of the pacemaker, stimulation of the heart 
commences. This is known as demand function. Pacemakers now are 
programmable and telemetric by means of an external programmer 
which can communicate bidirectionlly by radiofrequency. It can receive 
the present setting of rate, output, sensitivity and refractory periods as 
well as information on lead and battery impedance and current drains 
allowing assessment of the remaining battery life and settings to adjust 
the pacemaker to suit the patient’s need or prolong pacemaker life(60). 
TECHNIQUES OF PACEMAKER IMPLANTATION: 
     The implantation of a pacemaker is a surgical procedure requiring 
full sterile precautions performed by surgeons or cardiologists usually 
under local anaesthesia. The central cephalic approach by incision or the 
subclavian  percutaneously are veins the veins of choice for the lead, 
which consist of a multistrand conductor wire insulated by silicone 
rubber or polyurethane with an electrode tip usually of platinum alloy 
and a connector plug at the distal end. The lead is passed with the aid of 
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fluoroscopy and stiffening stylet in the core of the lead to the right 
atrium through the tricuspid valve, and positioned in the apex of the 
right ventricle. Lateral fluoroscopy is useful to confirm the position. 
Close to the electrode an anchoring device is fitted to the lead, which 
engages the right ventricular trabeculae. The most effective of these is a 
group of tines, which project outwards and backwards from the tips at 
an angle of 60 degrees. If an atrial lead is to be used it is guided through 
the same vein to the right atrium. Once the lead is in position tests are 
made of the signal that the heart will convey to the pacemaker via the 
lead (electrograms) and the ability of an external pacemaker attached to 
the lead to pace the heart (threshold testing). If the lead is found 
satisfactory, it is sutured in two layers, in the veins and the subcutaneous 
tissues and a subcutaneous pocket over pectoralis major is constructed 
for the pacemaker, which is attached to the lead and implanted. 
Prophylactic antibiotics are recommended for a few days after surgery. 
The patient is mobilized on the same day and discharged the next(60). 
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Complications  of pacemaker insertion :  
Complications are few but include the following:(2) 
• Infection; when a pacemaker system is infected, antibiotic treatment 
is not sufficient and the pacemaker must usually be removed before 
antibiotics will subdue the infection. Another pacemaker is fitted 
later. 
• Erosion; the pacemaker may erode through the skin .This is usually 
due to low-grade infection. Mechanical factors may also be 
responsible. 
• Pocket haematoma; bleeding into the pacemaker pocket may result in 
significant pain, swelling, and on occasions wound breakdown and 
extrusion of the pulse generator. To avoid this complication warfarin 
is routinely stopped prior to pacemaker implantation and surgery is 
deffered in patients with an INR > 1.5. 
• Lead displacement; in most cases the pacing lead is securely wedged 
into the trabeculae of the right ventricle. It takes approximately 6 
weeks for the pacing lead to become firmly adherent to the 
myocardium. Most lead displacements occur early, typically within 
the first 24 hours. Lead displacement rarely occurs after 6 weeks but 
when it does it may lead to sudden loss of pacing and a recurrence of 
prepacing symptoms. 
• Electromagnetic interference; this is not common with modern 
pacemakers. High-tension cables, high-energy radars, arc-welding 
 28 
equipment and some medical equipment, such as MRI machines and 
lithotripters, may transiently inhibit the output of pacemaker or 
convert it to interference mode(continuous pacing despite an 
adequate underlying rhythm).Digital cellular telephones may cause 
similar problems, but only when the telephone is held in very close 
proximity to the pulse generator. 
 
Advantages And Disadvantages Of Pacing Modes – In selecting the 
ideal pacing mode, the patient's overall physical condition, associated 
medical problems, exercise capacity and chronotropic response to 
exercise must be considered along with the underlying rhythm 
disturbance (61). Some of the various ventricular and atrial pacing 
systems available and their NBG codes are described in the tables. 
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Ventricular inhibited pacing – VVI or ventricular demand pacing 
(ventricle paced, ventricle sensed, and pacemaker inhibited in 
response to sensed beat) remains the most commonly used pacing 
mode. Although VVI pacing will protect the patient from lethal 
bradycardias, it does not restore or maintain atrioventricular 
synchrony, nor does it provide rate responsiveness in the 
chronotropically incompetent patient (i.e., the patient who cannot 
achieve an appropriate heart rate for a given physiologic activity). 
The earliest indication for cardiac pacing was high-grade or complete 
heart block with recurrent Stokes-Adams attacks. In patients with this 
disorder, establishing a stable ventricular rhythm was lifesaving and 
prevented catastrophic asystole. This fact alone overshadowed the 
observation that, although ventricular pacing improved cardiac output 
and/or patients' symptoms, it did not reestablish normal cardiac 
function. In addition, some patients with intermittent heart block 
experienced symptomatic hemodynamic deterioration with ventricular 
pacing (66,67). 
  Pacemaker syndrome – Adverse hemodynamics associated with a 
normally functioning pacing system, resulting in overt symptoms or 
limitation of the patient's ability to achieve optimal functional status, 
is referred to as pacemaker syndrome (66,67).The syndrome is 
characterized by the absence of AV synchrony, resulting in a decrease 
in stroke volume, and probable atrial contraction against a closed AV 
valve, similar to what is seen during complete heart block. Symptoms 
include presyncope or syncope, easy fatiguability, cough, dizziness, 
dyspnea, orthopnea, paroxysmal nocturnal dyspnea, and a sensation of 
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throat fullness. Physical examination may reveal hypotension, rales, 
increased jugular venous pressure with cannon A waves, peripheral 
edema, and murmurs of tricuspid and/or mitral regurgitation (66). 
These clinical manifestations are associated with a constellation of 
findings on transesophageal echocardiography. These include higher 
reverse flow velocity in the pulmonary veins compared to patients 
with VVI pacing but no pacemaker syndrome, spontaneous echo 
contrast in the descending aorta, and significant mitral 
regurgitation(69). 
Pacemaker syndrome was initially recognized in 5 to 15 percent of 
patients with ventricular (VVI) pacing. However, it can occur anytime 
there is AV dissociation (independent atrial and ventricular 
contraction), and it is now clear that it is a common occurrence. This 
was illustrated in a study in which 40 unselected patients with dual 
chamber pacemakers were entered into a blinded, randomized trial 
comparing the symptoms associated with VVI pacing to those 
associated with dual chamber pacing (67). Pacemaker syndrome was 
clinically recognized in 83 percent of patients paced in the VVI mode; 
65 percent experienced moderate to severe symptoms. 
The development of the pacemaker syndrome leads some patients to 
switch from VVI pacing. In one study in which 407 elderly patients 
with sick sinus syndrome or complete atrioventricular block were 
randomly assigned to either VVI or DDD pacing, 26 percent of 
patients assigned to VVI pacing crossed over to DDD pacing because 
of symptoms of pacemaker syndrome (69). 
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Atrial inhibited pacing – AAI pacing (atrium paced, a (atrium paced, 
atrium sensed, and pacemaker inhibited in response to sensed beat) is 
appropriate for patients with sinus node dysfunction who have intact 
AV nodal function. It is infrequently used in the United States. The 
obvious disadvantage of atrial pacing is lack of ventricular support 
should atrioventricular (AV) block occur. However, if the patient with 
sinus node dysfunction is assessed carefully for the presence of AV 
node disease at the time of pacemaker implant, the occurrence of 
clinically significant AV nodal disease is very low (less than 2 percent 
per year) (70). 
Assessment prior to use of an AAI system should include incremental 
atrial pacing at the time of pacemaker implant. Although criteria vary 
among institutions and implanting physicians, the adult patient should 
be capable of 1:1 AV nodal conduction to rates of 120 to 140 
beats/min. 
AV sequential pacing – DVI (atrium and ventricle paced, ventricular 
sensing only, and inhibition of pacemaker in response to sensed 
ventricular beat) pacemakers were at one time implanted in large 
numbers of patients, often with a very satisfactory outcome. However, 
DVI pacing is limited by the absence of atrial sensing, which prevents 
the restoration of rate-responsiveness in the chronotropically 
competent patient. In addition, lack of atrial sensing may lead to 
competitive atrial pacing and initiation of atrial rhythm disturbances. 
For these reasons, DVI pacing is rarely the mode of choice at the time 
of implant but remains a programmable option in many dual-chamber 
pacemakers. 
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DDI pacing – In the DDI, dual chamber pacing mode, there is atrial 
sensing and pacing, and ventricular sensing and pacing; however, the 
pacemaker is incapable of tracking intrinsic atrial activity. As a result, 
there is only a single rate programmed and the paced ventricular rate 
will never exceed the programmed rate. 
Atrial synchronous ventricular inhibited (VDD) pacing – VDD 
pacing (ventricle paced, atrium and ventricle sensed, and either 
inhibition or tracking of the pacemaker in response to a sensed beat) 
may be appropriate for the patient with normal sinus node function 
and conduction disease of the AV node. Dual chamber (two lead) 
VDD pacing systems have largely been supplanted by DDD 
pacemakers. However, VDD as the preimplant pacing mode of choice 
is gaining new acceptance with the introduction of single-lead VDD 
pacing systems (71,72). In this system, atrial sensing is accomplished 
from "floating" sensing electrodes on the atrial portion of the 
ventricular pacing lead. 
Dual chamber pacing – The dual chamber (DDD) pacing system 
combines the functions of ventricular, atrial, AV sequential, and atrial 
synchronous pacing, providing physiologic pacing. Pacing and 
sensing occur in both atrium and ventricle. 
  •  The pacemaker will be totally inhibited if sinus rhythm exists 
  •  The atrium is stimulated if sinus bradycardia exists 
  •  Both the atrium and ventricle are stimulated if bradycardia exists 
independently in both chambers 
  •  The ventricle will be paced in synchrony with the atrium if heart 
block exists with normal sinus function 
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Thus, there are four different rhythms that can be seen with normal 
pacemaker function : 
  •  Normal sinus rhythm 
  •  Atrial pacing 
  •  AV sequential pacing 
  •  P-synchronous pacing (ie, atrial sensing and ventricular pacing or 
P wave ventricular pacing) 
The DDD pacing mode is most appropriate for patients with normal 
sinus node function and AV block. DDD pacing is also considered by 
some to be the mode of choice in carotid sinus hypersensitivity with 
symptomatic cardioinhibition. 
  Physiologic versus VVI pacing – Dual chamber pacemakers have 
the following potential hemodynamic advantages over fixed rate VVI 
pacing: 
  •  Higher cardiac output and arterial pressure (73-75) 
  •  Preservation of coronary blood flow (76) 
  •  Fewer or absent symptoms of "pacemaker syndrome" (66,67,69) 
  •  Lower incidence of heart failure and less left atrial dilation (77) 
  •  Possible reductions in recurrent atrial fibrillation, mortality, and 
thromboembolic events (78-80); the last benefit may be due in part to 
better left atrial appendage function with higher emptying and filling 
flow velocity, as well as less platelet activation (76-81). 
The factors responsible for the reduction in atrial fibrillation are 
uncertain, although maintenance of AV synchrony may be important. 
In one report that compared VVI with DDD pacing in 30 patients, the 
loss of AV synchrony with VVI pacing was associated with atrial 
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electrical remodeling, which may promote atrial fibrillation; the 
remodeling was reversible after the restoration of AV synchrony with 
DDD pacing (82). 
Non-atrial mediated rate-adaptive pacemakers – These systems 
use a sensor (motion, vibration, minute ventilation, oxygen saturation, 
temperature) in a standard pacing mode, not based upon the sinus 
node rate, which allows for a rate response to stress. Following 
detection of movement or exercise, there is an increase in pacing rate. 
Such rate responsive pacemakers are indicated for patients who 
require an increase in heart rate in response to activity but who are 
chronotropically incompetent, i.e., they are unable to increase the 
heart rate in response to activity. 
  VVIR pacing – VVIR pacing, like VVI pacing, is contraindicated if 
ventricular pacing results in retrograde (VA) conduction and/or a fall 
in blood pressure. VVIR pacing should not be used as an excuse to 
forego attempts at placing an atrial lead in a patient who is undergoing 
pacemaker implantation, has normal sinus node function, and would 
benefit from rate-adaptive pacing. If the sinus node is intact, P-
synchronous pacing should still be considered the optimal rate-
adaptive parameter and used whenever possible. 
There have been many studies comparing DDD and VVIR pacing. As 
an example, a randomized crossover design was used to evaluated 18 
patients with complete heart block: cardiopulmonary performance and 
quality of life measures were similar with the two modes, although 
patients had a greater sense of well-being with DDD pacing (83). 
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VVIR pacing is indicated in patients with chronic atrial fibrillation 
with a slow ventricular response. 
  AAIR pacing – AAIR pacing can be considered in the patient with 
sinus node dysfunction and normal AV node function, since this mode 
will restore rate responsiveness and maintain AV synchrony. If AAIR 
(or AAI) pacing is contemplated, normal AV node conduction must 
first be determined. As noted above, this assessment should include 
incremental atrial pacing at the time of pacemaker implant. Although 
criteria vary among institutions and implanting physicians, the adult 
patient should be capable of 1:1 AV nodal conduction to rates of 120 
to 140 beats/min. 
  DDDR pacing – The ideal patient for DDDR pacing is one with 
combined sinus nodal and AV nodal dysfunction in whom DDDR 
pacing would restore rate responsiveness and AV synchrony. In a 
patient with paroxysmal atrial rhythm disturbances, for example, 
programming the pacemaker to the DDIR mode will allow rate 
modulation and AV synchrony but not allow tracking of any rapid 
pathological atrial rhythms. 
  Mode switching pacing – Pacemakers are now available that can 
mode switch in response to atrial arrhythmias. Such pacemakers will 
automatically switch from an atrial tracking mode to a mode not 
capable of atrial tracking, e.g., DDD to VVI mode, in response to 
rapid atrial rates as occur with atrial flutter and atrial fibrillation. 
These pacemakers avoid the potential for rapid paced ventricular rates 
if such arrhythmias occur in patients who have pacemakers capable of 
 40 
atrial tracking. The following potential mode-switch combination are 
available in current generators: 
          DDDR to DDIR 
          DDDR to VVIR 
          DDD to DDIR 
          DDD to VVI 
          VDDR to VVIR 
          VDD to VVIR 
          VDD to VVI 
One report evaluated 48 patients with a history of paroxysmal atrial 
tachyarrhythmias and complete heart block who had a mode switching 
pacemaker; the patients preferred this pacing mode over conventional 
DDDR or VVIR pacing (84). Inappropriate mode switching and 
tracking of atrial tachyarrhythmias was very uncommon. 
Algorithms – A number of algorithms are available for determining 
the appropriate pacing mode for patients with sinus node disease and 
AV node disease. The first, more complex algorithms consider most of 
the available pacing modes. The second algorithm is simpler and 
assumes that a pacemaker capable of rate-adaptation will be used (see 
figure). 
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Results of cardiac pacing: 
Permanent pacing results in abolition of dizziness and syncope 
and marked prolongation in life expectancy in AV block. It is now 
emerging that dual chamber pacing gives improve life expectancy over 
ventricular pacing when heart failure is the presenting feature and atrial 
or dual chamber pacing also offers benefits in life expectancy in sick 
sinus syndrome.  
With modern pacing systems re-operation is rarely necessary until 
battery exhaustion is immanent(60).  
The history of cardiac pacing in Sudan:   
The first temporary pacing in Sudan started in 1989 in Elshaab 
teaching hospital where it was performed by Mr. M. Saeed Elfeil. 
The second temporary pacing was performed by Dr. Ahmed 
Babieker in June 1996 in Elshaab teaching hospital. 
In August 1996, and as a revolution, the first permanent 
pacemaker implantation was performed in Ibn Sina hospital by Dr. 
Ahmed Babieker and Mr. Ibn Aouf. Two VVI pacemakers were inserted 
to two patients with CHB. The operation passed peacefully and 
successfully. The first patient died of a different disease and the second 
one underwent pulse generation replacement ten years later, he is still 
alive and well.       
  
 
 
 
 43 
OBJECTIVES 
 
 
1. To study the clinical characteristics and presentations of 
Sudanese patients with complete heart block. 
2. To study the different modes of cardiac pacing used in Sudan. 
3. To study the short-term outcome of cardiac pacing. 
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PATIENTS AND METHODS  
This is a descriptive, analytical, partially retrospective and 
partially prospective study. 
 Study Area: 
      Sudan Heart Center. It is the third cardiac center in Sudan. It has 
been constricted in 2001. It is an advanced center where most of the 
cardiac investigations and operations are performed.   
Study Population: 
      Patients with complete heart block who presented to or referred to 
SHC in the period from January to December 2004. 
Inclusion Criteria: 
        Patients who underwent cardiac pacing in SHC in the appropriate 
period. 
Exclusion Criteria: 
Patients with CHB but refused or could not afford the cost of 
cardiac pacing. 
Data Collection: 
- Simple consecutive sampling. 
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- Data was collected by self-administered questionnaire that was 
constructed in sections to address the different aspects of the study 
including: 
        a. Personal data 
        b. Presenting symptoms 
        c. Physical signs 
        d. Important investigations 
       e. Modes of cardiac pacing 
       f. Short term outcome of cardiac pacing 
Data Analysis: 
The collected data was entered in a master sheet and analyzed in a 
statistical manner using SPSS (Statistical package for Social Sciences), 
the results were expressed in frequencies and percentages. 
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RESULTS 
In the period from January to December 2004, a total of 70 
patients with CHB who underwent cardiac pacing in SHC were studied. 
Those patients were followed up for 12 weeks to assess the short term 
outcome of the cardiac pacing on clinical basis. 
The results of the study were as follows: 
Sex Distribution: 55.6% of the patients were males and 44.3% 
were females with a male to female ratio 1.3:1. (Figure-1) 
Age Distribution: The ages of the patients on presentation 
ranged from 35 to 85 years, with a mean age 64.6 years and the mode 
was 70 years. (Table-1) 
Associated Diseases: 22.9% were hypertensive, 7.1% were 
diabetic, 15.7% had IHD, 21.4% had HTN, DM, IHD diseases and 
32.9% had no associated diseases. (Table-2) 
Presenting symptoms : The presenting symptoms were dyspnoea 
(52.3%), syncope (45.7%), dizziness (40%), chest pain (21.4%), cough 
(24.3%), palpitations (21.4%), L.L oedema (24.9%), fatigability 
(15.7%), convulsions (4.3%), confusion (4.3%), and vertigo (1.4%). 
(Figure-2) 
 47 
Drugs: 12.9% of the patients were in Calcium Channel Blockers, 
5.7% in Beta Blockers and 48.6% were using other drugs (Diuretics, 
Vasodilators, ACE inhibitors, Oral Hypoglycaemic Agents and Insulin). 
No patient was using Digitalis therapy. (Table-3) 
Presenting signs : The main signs on examining the patients 
were bradycardia (88.4%) (Table-4), tachypnoea (31.4), and signs of 
heart failure (25.7%). (Figure-3) 
The JVP was raised in 34.3%, (25.7% in heart failure and 8.6% 
had giant cannon waves but not in failure). 
Blood pressure levels : On measuring the BP of those patients, 
11.4% were hypotensive, 40.7% were normotensive, 45.7% had systolic 
hypertention and only 2.9% had systolic and diastolic hypertension. 
(Table-5)     
ECG findings : ECG showed CHB alone in 74.3%, CHB and 
RBBB in7.1%, CHB and ST segment and T wave changes in 15.7% and 
CHB with LBBB in 2.9%. (Figure-4) 
ECHO findings : ECHO studies were normal in 31.4% of the 
patients while 25.7% had LVH with good systolic function, 15.7% had 
left ventricular dilatation with poor systolic function, 14.3% had 
ischaemic changes, 7.1% had ischaemic changes and dilated 
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cardiomyopathy, 2.9% had aortic valve sclerosis and 1.4% had mitral 
valve sclerosis. (Table-6) 
Renal Function: 92.9% of the patients had normal renal function 
and 7.1% had renal impairment. Only 1.4% had hyperkalaemia.             
(Table-7) 
Different modes of permanent pacemakers were implanted; VDD 
in 54/3%, VVI in 25.7%, DDD in 12.9%, DDDR in 4.3% and VVIR in 
2.9%. (Figure-5) 
Complications of Pacemaker Implantation : (85.7%) of the 
patients developed no complications peri or postoperatively, while only 
(14.3%) develop complications including bleeding (2.9%), infection 
(2.9%), lead displacement (4.3%), erosion through skin (2.9%) and 
pneumothorax (1.4%). (Table-8) 
The short-term outcome :  91.4% of the patients improved after 
pacing mainly those with VDD pacing, (94.7% out of 83 patients 
improved) and in those with VVI pacing, (83.3% out of 80 patients 
improved). No significant difference regarding the outcome comparing 
VDD pacing versus VVI pacing. (Figure-6) 
The improvement was shown by resolution of symptoms and 
better life performance.  
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Table (1):  Age group distribution in the study  population :  
 
Age group in years Frequency Percentage 
35 – 45 5 7.1 
64 – 55 12 17.1 
56- 65 17 24.3 
66-75 27 38.6 
76 -85 9 12.9 
Total 70 100.0 
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Table (2):  Incidence of associated diseases (DM, HTN, IHD) in 
study population :   
 
Diseases (s) No. of patients Percentage 
DM 5 7.1 
HTN 16 22.9 
I HD 11 15.7 
DM + HTN 3 4.3 
DM + IHD 2 2.9 
HTN+IHD 5 7.1 
DM + HTN + IHD 5 7.1 
NO 23 32.9 
Total 70 100.0 
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Table (3):  Drugs used  by the  study  population:   
 
Drug  Frequency Percentage 
Beta blockers  4 5.7 
Calcium channel blockers  9 12.9 
Digoxin  0 0 
Other drugs  34 48.6 
No drugs  23 32.9 
Total  70 100.0 
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Table (4):  Pulse rate in the  study  population :  
 
Pulse rate  (bpm) Frequency Percentage 
25 – 35 12 17.2 
36 – 45 37 52.8 
46 – 55 13 18.5 
56 – 65 8 11.6 
Total 70 100 
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Table (5):  Distribution of BP in the study  population :  
 
BP Frequency Percentage 
Low 8 11.4 
Normal 28 40.0 
Systolic hypertension 32 45.7 
Hypertension  2 2.9 
Total 70 100 
 
N.B.:  
Low < 100/60 
High > 140/90 
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Table (6): ECHO findings in the study population:  
 
ECHO finding  No. of patients Percentage 
Normal  22 31.4 
LVH with  good  systolic function  18 25.7 
Left ventricular dilatation with poor  
systolic  function  
11 15.7 
IHD  10 14.3 
IHD + DCM 5 7.1 
Aortic  valve  sclerosis   2 2.9 
Mitral valve  sclerosis 1 1.4 
AVR + heald  vegetation  1 1.4 
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Table (7): S. creatinine levels  in the study  population : 
 
S. creatinine levels   Frequency Percentage 
Normal  65 92.9 
High 5 7.1 
Total  70 100.0 
 
N.B.: Normal < 1.5mg/dl 
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Table  (8):  Complications of  pacemaker insertion : 
  
Complication  No. of patients Percentage
No complications  60 85.7 
Bleeding  2 2.9 
Infection  2 2.9 
Lead displacement  3 4.3 
Infection with erosion through skin 2 2.9 
Pneumothorax  1 1.4 
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Figure (1) : Sex distribution in the study population 
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Figure (2):  Presenting Symptoms 
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Figure (3):  Presenting Signs  
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Figure  (4):  ECG finding in the study  population 
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Figure (5):  Modes of  cardiac pacing in the  study  population  
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Figure (6): Short term outcome of cardiac pacing 
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DISCUSSION 
            In this study 70 patients underwent cardiac pacing, 65 primary 
pacemaker implantation and 5 pulse generator replacement. The site of 
the conduction delay and the underlying etiology were not satisfactorily 
determined. This is usual from a practical point, most centers do not 
further investigate patients with electrophysiological study (EPS). This 
is compared to the most recent data concerning the incidence of cardiac 
pacing for the United States 1993 world survey on cardiac pacing (93). In 
1993, there were 426 pacemakers per million population with an 
estimated 112,064 primary pacemaker implantation and 20,965 pulse 
generator replacements. Sinus node dysfunction was the most frequent 
indication for pacing followed by AV node dysfunction. Pacing for 
tachyarrhythmias and miscellaneous indications accounted for only a 
small percentage. 
          In our study, males are more affected than the females. Most of 
the patients were elderly with the average age being 64.6 years and the 
commonest age on presentation was 70 years; but still 3 patients were 
young (<40 yrs) and 19 patients were in the middle age group              
(40-60 yrs). The patients presented with different clinical manifestations 
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mainly dizziness, syncope and dyspnoea, 2 patients presented with 
convulsions and one patient was  asymptomatic and discovered during 
routine examination. On examining the patients, 18 patients were in 
heart failure, 24 patients had raised JVP, and 32 patients had systolic 
hypertension. Unfortunately no reference studies were found with 
regards to the different clinical manifestations of CHB in other 
populations.  
In our study, different modes of cardiac pacing were used 
including VDD in 54.3%, DDD in12.9%, VVI in25.7%, DDDR in4.3% 
and VVIR in 2.9%. Pacemaker implantation is generally safe and only 
10 patients developed complications including; bleeding with pocket 
haematoma (2.9%), infection (2.9%), lead displacement (4.3%),erosion 
through skin (2.9%) and pneumothorax (1.4%). The patients were 
followed up for 12 weeks and the short term outcome was good. 91.4% 
of the patients improved and only 8.6% deteriorated, mostly due to lead 
displacement and pacemaker infection. Comparing DDD to VVI pacing; 
88.9% of the patients with DDD pacing improved compared to 83.3% 
with VVI pacing. Moreover, 11.1% of the patients with DDD pacing 
deteriorated compared to 16.7% with VVI pacing The outcome of 
cardiac pacing in the patients who presented in heart failure was good; 
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17 patients improved and only one patient, with VVI pacemaker, had his 
symptoms deteriorated and 6 weeks later he was crossed over to DDD 
pacemaker with evident improvement. 
          This study is compared to many randomized studies that have 
produced somewhat conflicting results concerning the long-term 
benefits of DDD compared to VDD or VVI pacing: 
• Wiegand and his friends, in 1999 studied the implications for single 
lead VDD pacing. 441 patients with complete AV block treated with 
either VDD or DDD pacemakers They found that the cumulative 
incidence of sinus node disease was 0.65% per year and only 0.2% 
of the patients were symptomatic. The cumulative incidence of atrial 
fibrillation was 2% per year regardless of the mode of  pacing (86). 
• Lamas and his friends, the PASE trial, in 1998 randomly assigned 
407 elderly patients (average age 76) with sick sinus syndrome or 
CHB to rate responsive VVI or DDD pacing. At 30 months, no 
difference was observed in total mortality, atrial fibrillation, or the 
combined end point of stroke, hospitalization for heart failure, or 
death. However, in the subset of patients with a sick sinus 
syndrome, DDD pacing was associated with reductions of borderline 
stastistical significance in mortality (12 versus 20 percent), atrial 
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fibrillation (19 versus 28 percent), and the combined end point of 
stroke, hospitalization for heart failure, or death (20 versus 31 
percent), and the modest increases in quality of life and functional 
status. During follow-up, 26 percent of the patients crossed over 
from VVI to DDD pacing because of symptoms related to 
pacemaker syndrome. (69,79) 
• Connolly and his friends, the much larger Canadian Trial of 
Physiologic Pacing (CTOPP), in 2000 randomly assigned 2568 
patients to VVI or physiologic(AAI or DDD) also found no 
difference between the groups in the primary end point or 
cardiovascular death or stroke(5.5 versus 4.9 events per year, the 
annual rate of all-cause mortality(6.6 versus 6.3 percent), and 
functional capacity as assessed with a six minute walk. The only 
benefit was not apparent until two years after the implantation. 
There were significantly more perioperative complications with 
physiologic pacing (9 versus 3.8 percent). (88) 
• Jahangir and his friends, in 1999 studied the value of ventricular or 
dual chamber pacing in the very elderly retrospectively, in a report 
of 432 patients (average age 85). After a 3.5 year follow-up, there 
was no difference in survival between patients with a sick sinus 
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syndrome receiving either type of pacemaker and that expected in an 
age-matched population; in comparison, survival after pacemaker 
insertion in patients with high grade AV block was significantly 
lower compared to expected survival of age and gender-matched 
population. Ventricular pacing was associated with a poorer survival 
compared with dual chamber pacing in this group.(89) 
• Deharo and his friends, in 1996 evaluated 18 patients with CHB in a 
randomized crossover design comparing DDD and VVIR pacing: 
cardiopulmonary performance and quality of life were similar with 
the two modes, although patients had a greater sense of well-being 
with DDD pacing. (83)         
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CONCLUSION 
• CHB is mainly a disease that increases with advancing age in Sudan 
but occasionally occurs in young people. 
• Cardiac pacing is relatively simple procedure with few 
complications. 
• Cardiac pacing improved the clinical status of patients with CHB 
especially those in heart failure improved significantly after pacing. 
• VVI pacing is still used in Sudan only due to financial restraints 
with good outcome.  
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RECOMMENDATIONS 
• Elderly people who presented with convulsions, recurrent falls or 
their complications (fractures, SDH) should be investigated for AV 
block. 
• Early detection and treatment of the causes of AV block are needed 
to decrease the incidence of CHB and the need for cardiac pacing. 
• Cardiac pacing is a life saving procedure and should be available in 
every cardiac center.  
• More research is needed in the field in Sudan.  
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 1
Questionnaire 
 
Index No.  
Name : ………………………………………………………………………. 
Sex    :                  M                   F 
Age   :   
HTN :    Yes                     No 
DM   :    Yes                     No 
IHD  :    Yes                     No 
History: 
A symptomatic :   Yes                 No 
Dizziness          :   Yes                 No 
Syncope            :   Yes                 No 
Confusion         :   Yes                 No 
Chest pain        :    Yes                 No 
S.O.B                :   Yes                 No 
Cough               :   Yes                 No 
L.L swelling     :   Yes                 No 
Others               :   Yes                 No 
 If   Yes   specify …………………………………………………………… 
Drugs               :  
1) Diyoxin 
2) Beta bloker 
3) Calcium channel blocker 
4) Others, specify……………………………………………………………… 
Physical examination: 
1) Confused                        Yes                 No 
2) Tachypnoec                           Yes                     No 
3) Pulse rate     
4) BP                       
5) Raised JVP         Yes                         No 
6) Murmur or added sounds        Yes                          No 
7) Basal crepitations                    Yes                          No 
 2
8) Hepatomegaly                     Yes                 No 
9) L.L. Oedema                       Yes                 No 
Investigations: 
1) ECG: ………………………………………………………………………… 
………………………………………………………………………. 
2) ECHO: ………………………………………………………………………. 
………………………………………………………………………... 
3) S.K+ 
4) B. Urea 
5) S. Creatinine  
Mode of cardiac pacing: 
1) VVI 
2) DDD 
3) Others, specify………………………………………… 
Complications  
1) Bleeding                           Yes                        No 
2) Failure of route                 Yes                       No 
     If Yes Specify: 
Outcome in three months: 
1) Improved 
2) Static 
3) Deteriorated  
4) Died  
 
  
